[
  {
    "title": "【龙虎榜】仟源医药1月3日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2023/01/03181137255994.shtml",
    "datetime": "2023-01-03 18:11:53",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：1364.76万股限售股11月10日解禁 占比5.65%",
    "href": "http://stock.jrj.com.cn/2022/11/07183137117907.shtml",
    "datetime": "2022-11-07 18:31:33",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)上半年净亏损2282.56万元",
    "href": "http://stock.jrj.com.cn/2022/08/25193936936912.shtml",
    "datetime": "2022-08-25 19:39:52",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：子公司取得一种纯化帕瑞昔布钠的设备及方法的发明专利证书",
    "href": "http://stock.jrj.com.cn/2022/06/02173836700951.shtml",
    "datetime": "2022-06-02 17:38:57",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：拟以1.05亿元向仟源保灵进行增资",
    "href": "http://stock.jrj.com.cn/2022/06/02173736700956.shtml",
    "datetime": "2022-06-02 17:37:04",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：拟使用闲置募集资金不超5000万元暂补日常经营所需的流动资金",
    "href": "http://stock.jrj.com.cn/2022/06/02173436700959.shtml",
    "datetime": "2022-06-02 17:34:28",
    "code": "300254"
  },
  {
    "title": "仟源医药2021年亏损9143.76万同比亏损减少 董事长黄乐群薪酬20.59万",
    "href": "http://stock.jrj.com.cn/2022/04/29215036507918.shtml",
    "datetime": "2022-04-29 21:50:48",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)一季度净亏损154.06万元 同比转亏",
    "href": "http://stock.jrj.com.cn/2022/04/29024136497794.shtml",
    "datetime": "2022-04-29 02:41:48",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：2021年年报延至4月29日披露",
    "href": "http://stock.jrj.com.cn/2022/04/21163736419423.shtml",
    "datetime": "2022-04-21 16:37:21",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：定增申请获证监会注册批复",
    "href": "http://stock.jrj.com.cn/2022/04/18164036385167.shtml",
    "datetime": "2022-04-18 16:40:31",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：子公司嘉逸医药获得高新技术企业证书",
    "href": "http://stock.jrj.com.cn/2022/03/24202534935707.shtml",
    "datetime": "2022-03-24 20:25:44",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：以简易程序向特定对象发行股票申请获深交所受理",
    "href": "http://stock.jrj.com.cn/2022/03/22211934862359.shtml",
    "datetime": "2022-03-22 21:19:02",
    "code": "300254"
  },
  {
    "title": "【龙虎榜】仟源医药2月21日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/02/21180534423213.shtml",
    "datetime": "2022-02-21 18:05:04",
    "code": "300254"
  },
  {
    "title": "仟源医药：控股子公司受托生产新冠药品仿制药的物质实体",
    "href": "http://stock.jrj.com.cn/2022/02/21135034422081.shtml",
    "datetime": "2022-02-21 13:50:08",
    "code": "300254"
  },
  {
    "title": "A股异动 | 仟源医药六日累涨逾48% 控股子公司受托生产新冠药品仿制药的物质实体",
    "href": "http://stock.jrj.com.cn/2022/02/21094234418133.shtml",
    "datetime": "2022-02-21 09:42:12",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：拟使用闲置募集资金不超5000万元暂补流动资金",
    "href": "http://stock.jrj.com.cn/2022/02/18210834399794.shtml",
    "datetime": "2022-02-18 21:08:25",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：老挝药企委托嘉逸医药生产默药仿制药物质实体",
    "href": "http://stock.jrj.com.cn/2022/02/18171934392519.shtml",
    "datetime": "2022-02-18 17:19:03",
    "code": "300254"
  },
  {
    "title": "仟源医药：子公司签订抗新冠药品《委托加工合作协议》",
    "href": "http://stock.jrj.com.cn/2022/02/18171734392507.shtml",
    "datetime": "2022-02-18 17:17:28",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：子公司通过高新技术企业重新认定",
    "href": "http://stock.jrj.com.cn/2022/02/07205934303182.shtml",
    "datetime": "2022-02-07 20:59:52",
    "code": "300254"
  },
  {
    "title": "A股异动 | 仟源医药(3002541.SZ)涨19.97% 子公司获批开展新型冠状病毒核酸检测",
    "href": "http://stock.jrj.com.cn/2022/01/27093834229019.shtml",
    "datetime": "2022-01-27 09:38:25",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：子公司获批开展新型冠状病毒核酸检测",
    "href": "http://stock.jrj.com.cn/2022/01/26170634223710.shtml",
    "datetime": "2022-01-26 17:06:33",
    "code": "300254"
  },
  {
    "title": "仟源医药2021年预计亏损8500万-1.2亿 较上年同期亏损减少",
    "href": "http://stock.jrj.com.cn/2022/01/25051234207779.shtml",
    "datetime": "2022-01-25 05:12:09",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：西藏仟源近日获得产业发展扶持资金500万元",
    "href": "http://stock.jrj.com.cn/2022/01/24202634206243.shtml",
    "datetime": "2022-01-24 20:26:35",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：2021年度预亏0.85亿元-1.2亿元",
    "href": "http://stock.jrj.com.cn/2022/01/24202034206220.shtml",
    "datetime": "2022-01-24 20:20:48",
    "code": "300254"
  },
  {
    "title": "【龙虎榜】仟源医药12月29日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/12/29180434082169.shtml",
    "datetime": "2021-12-29 18:04:32",
    "code": "300254"
  },
  {
    "title": "【龙虎榜】仟源医药12月27日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/12/27180634071669.shtml",
    "datetime": "2021-12-27 18:06:03",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：两子公司近日共收到政府补助281.36万元",
    "href": "http://stock.jrj.com.cn/2021/12/24170234058227.shtml",
    "datetime": "2021-12-24 17:02:45",
    "code": "300254"
  },
  {
    "title": "仟源医药股东左学民减持46.28万股 套现约293.16万 第三季度公司亏损126.89万",
    "href": "http://stock.jrj.com.cn/2021/11/26043833920501.shtml",
    "datetime": "2021-11-26 04:38:45",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：监事会主席左学民已减持46.28万股",
    "href": "http://stock.jrj.com.cn/2021/11/25173233919440.shtml",
    "datetime": "2021-11-25 17:32:18",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：子公司以自有资产抵押向银行申请不超1000万元贷款",
    "href": "http://stock.jrj.com.cn/2021/11/22165733904244.shtml",
    "datetime": "2021-11-22 16:57:48",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：监事会主席左学民已减持38.5万股",
    "href": "http://stock.jrj.com.cn/2021/11/16170033860670.shtml",
    "datetime": "2021-11-16 17:00:49",
    "code": "300254"
  },
  {
    "title": "仟源医药董事长黄乐群增持20.14万股 耗资126万 第三季度公司亏损126.89万",
    "href": "http://stock.jrj.com.cn/2021/11/11183233837234.shtml",
    "datetime": "2021-11-11 18:32:04",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：董事长黄乐群再增持20.14万股",
    "href": "http://stock.jrj.com.cn/2021/11/11172133836832.shtml",
    "datetime": "2021-11-11 17:21:29",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：董事长黄乐群再增持48.55万股",
    "href": "http://stock.jrj.com.cn/2021/11/09174233828207.shtml",
    "datetime": "2021-11-09 17:42:32",
    "code": "300254"
  },
  {
    "title": "仟源医药：董事长近两日增持公司股份 董监高或继续增持",
    "href": "http://stock.jrj.com.cn/2021/11/03212633809791.shtml",
    "datetime": "2021-11-03 21:26:49",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：获董事长黄乐群累计增持58.79万股",
    "href": "http://stock.jrj.com.cn/2021/11/03171133808942.shtml",
    "datetime": "2021-11-03 17:11:54",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)子公司获得一项发明专利",
    "href": "http://stock.jrj.com.cn/2021/11/02182133804350.shtml",
    "datetime": "2021-11-02 18:21:41",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：子公司获得政府补助405.06万元",
    "href": "http://stock.jrj.com.cn/2021/11/01212433799963.shtml",
    "datetime": "2021-11-01 21:24:24",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：董事长黄乐群累计增持65.93万股",
    "href": "http://stock.jrj.com.cn/2021/11/01212333799961.shtml",
    "datetime": "2021-11-01 21:23:29",
    "code": "300254"
  },
  {
    "title": "仟源医药：董事长近期增持0.29%股份 公司董监高不排除继续增持可能",
    "href": "http://stock.jrj.com.cn/2021/11/01173433798706.shtml",
    "datetime": "2021-11-01 17:34:31",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：第三季度净亏损126.89万元",
    "href": "http://stock.jrj.com.cn/2021/10/26192633756400.shtml",
    "datetime": "2021-10-26 19:26:19",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：总裁钟海荣因工作原因辞职",
    "href": "http://stock.jrj.com.cn/2021/10/22164933733629.shtml",
    "datetime": "2021-10-22 16:49:48",
    "code": "300254"
  },
  {
    "title": "仟源医药股东左学民拟减持不超46.29万股公司股份 上半年公司亏损411.86万",
    "href": "http://stock.jrj.com.cn/2021/09/15184033440701.shtml",
    "datetime": "2021-09-15 18:40:54",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：监事会主席左学民拟减持不超46.29万股",
    "href": "http://stock.jrj.com.cn/2021/09/15164133439966.shtml",
    "datetime": "2021-09-15 16:41:58",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：子公司撤回安立生坦片药品注册申请",
    "href": "http://stock.jrj.com.cn/2021/09/03173033380847.shtml",
    "datetime": "2021-09-03 17:30:57",
    "code": "300254"
  },
  {
    "title": "仟源医药：拟定增不超1.3亿元，将用于药品研发项目",
    "href": "http://stock.jrj.com.cn/2021/08/30115033351024.shtml",
    "datetime": "2021-08-30 11:50:48",
    "code": "300254"
  },
  {
    "title": "仟源医药2021年半年度亏损411.86万元 同比亏损减少94.53%",
    "href": "http://stock.jrj.com.cn/2021/08/27211533335997.shtml",
    "datetime": "2021-08-27 21:15:07",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：子公司获得产业发展扶持资金300万元",
    "href": "http://stock.jrj.com.cn/2021/07/01170633027982.shtml",
    "datetime": "2021-07-01 17:06:21",
    "code": "300254"
  },
  {
    "title": "仟源医药：公司无红桃K保健食品的生产及销售",
    "href": "http://stock.jrj.com.cn/2021/06/17210532949719.shtml",
    "datetime": "2021-06-17 21:05:37",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：子公司通过高新技术企业重新认定",
    "href": "http://stock.jrj.com.cn/2021/06/09163532900057.shtml",
    "datetime": "2021-06-09 16:35:11",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：拟受让四川仟源8.6429%的股权 持股升至51%",
    "href": "http://stock.jrj.com.cn/2021/05/27213932832077.shtml",
    "datetime": "2021-05-27 21:39:12",
    "code": "300254"
  },
  {
    "title": "A股异动 | 仟源医药(300254.SZ)涨4.42% 子公司获发明专利证书",
    "href": "http://stock.jrj.com.cn/2021/05/18101932774409.shtml",
    "datetime": "2021-05-18 10:19:05",
    "code": "300254"
  },
  {
    "title": "仟源医药：公司相关产品都可能会受益于生育政策放开的影响",
    "href": "http://stock.jrj.com.cn/2021/05/10163032730012.shtml",
    "datetime": "2021-05-10 16:30:36",
    "code": "300254"
  },
  {
    "title": "仟源医药：目前仟源恩氏是全国首家个人实物基因保存机构",
    "href": "http://stock.jrj.com.cn/2021/05/10162632729979.shtml",
    "datetime": "2021-05-10 16:26:50",
    "code": "300254"
  },
  {
    "title": "仟源医药：公司暂无计划发展医美行业",
    "href": "http://stock.jrj.com.cn/2021/05/10162132729955.shtml",
    "datetime": "2021-05-10 16:21:07",
    "code": "300254"
  },
  {
    "title": "仟源医药：未来公司仍将开展慢性病等领域高端仿制药的研发",
    "href": "http://stock.jrj.com.cn/2021/05/10162132729953.shtml",
    "datetime": "2021-05-10 16:21:05",
    "code": "300254"
  },
  {
    "title": "仟源医药：今年公司将加大盐酸西那卡塞片等新产品的营销力度",
    "href": "http://stock.jrj.com.cn/2021/05/10162032729926.shtml",
    "datetime": "2021-05-10 16:20:42",
    "code": "300254"
  },
  {
    "title": "仟源医药：公司目前拥有儿童用药蒙脱石散、维生素AD滴剂及孕妇保健品保灵孕宝口服液等产品的销售",
    "href": "http://stock.jrj.com.cn/2021/05/10161832729923.shtml",
    "datetime": "2021-05-10 16:18:15",
    "code": "300254"
  },
  {
    "title": "【龙虎榜】仟源医药4月28日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/04/28180632472873.shtml",
    "datetime": "2021-04-28 18:06:54",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：1966.2921万股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2021/04/09222832344938.shtml",
    "datetime": "2021-04-09 22:28:03",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：子公司嘉逸医药获得政府补助200万元",
    "href": "http://stock.jrj.com.cn/2021/03/18162432157277.shtml",
    "datetime": "2021-03-18 16:24:08",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：子公司仟源海力生收到政府补助310万元",
    "href": "http://stock.jrj.com.cn/2021/03/04165132071438.shtml",
    "datetime": "2021-03-04 16:51:48",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：子公司获得政府补助400万元",
    "href": "http://stock.jrj.com.cn/2021/03/01172432051128.shtml",
    "datetime": "2021-03-01 17:24:49",
    "code": "300254"
  },
  {
    "title": "仟源医药2020年度亏损2.59亿由盈转亏 药品销售价格降价",
    "href": "http://stock.jrj.com.cn/2021/02/26221132035742.shtml",
    "datetime": "2021-02-26 22:11:37",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)业绩快报：2020年度业绩盈转亏至2.59亿元",
    "href": "http://stock.jrj.com.cn/2021/02/26192932034745.shtml",
    "datetime": "2021-02-26 19:29:38",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)拟使用闲置募集资金不超5000万元暂时补充流动资金",
    "href": "http://stock.jrj.com.cn/2021/02/08214331872625.shtml",
    "datetime": "2021-02-08 21:43:05",
    "code": "300254"
  },
  {
    "title": "仟源医药2020年预计亏损2.2亿-2.86亿同比由盈转亏 商誉减值约5200万",
    "href": "http://stock.jrj.com.cn/2021/01/31150031816666.shtml",
    "datetime": "2021-01-31 15:00:54",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：股东赵群解除质押182.8万股及质押展期685.05万股",
    "href": "http://stock.jrj.com.cn/2021/01/18163331715534.shtml",
    "datetime": "2021-01-18 16:33:00",
    "code": "300254"
  },
  {
    "title": "仟源医药股东翁占国减持183.8万股 股份减少0.81%",
    "href": "http://stock.jrj.com.cn/2021/01/15204131701265.shtml",
    "datetime": "2021-01-15 20:41:21",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：股东翁占国近日通过大宗交易方式合计减持183.8万股",
    "href": "http://stock.jrj.com.cn/2021/01/15172831699962.shtml",
    "datetime": "2021-01-15 17:28:35",
    "code": "300254"
  },
  {
    "title": "仟源医药：持股5%以上股东翁占国近期减持231.10万股 占公司总股本比例1.01%",
    "href": "http://stock.jrj.com.cn/2021/01/07165031648922.shtml",
    "datetime": "2021-01-07 16:50:43",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：持股5%以上股东翁占国大宗交易减持比例达1%",
    "href": "http://stock.jrj.com.cn/2021/01/07161331648264.shtml",
    "datetime": "2021-01-07 16:13:13",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：子公司获得产业发展扶持资金300万元",
    "href": "http://stock.jrj.com.cn/2020/12/11174331465664.shtml",
    "datetime": "2020-12-11 17:43:19",
    "code": "300254"
  },
  {
    "title": "仟源医药：拟使用募集资金1.15亿元向全资子公司仟源保灵进行增资",
    "href": "http://stock.jrj.com.cn/2020/11/27184031361921.shtml",
    "datetime": "2020-11-27 18:40:11",
    "code": "300254"
  },
  {
    "title": "仟源医药：西藏仟源近日获得600万元产业发展扶持资金",
    "href": "http://stock.jrj.com.cn/2020/11/18174031308837.shtml",
    "datetime": "2020-11-18 17:40:16",
    "code": "300254"
  },
  {
    "title": "仟源医药前三季度亏损1.24亿 部分产品退出医保目录",
    "href": "http://stock.jrj.com.cn/2020/10/29095631155950.shtml",
    "datetime": "2020-10-29 09:56:25",
    "code": "300254"
  },
  {
    "title": "仟源医药：收到由大同市经济技术开发区财政局拨付的补助金额合计325万元",
    "href": "http://stock.jrj.com.cn/2020/10/23193931118185.shtml",
    "datetime": "2020-10-23 19:39:18",
    "code": "300254"
  },
  {
    "title": "仟源医药2020年前三季度亏损1.23亿-1.28亿 抗感染药物销售下滑",
    "href": "http://stock.jrj.com.cn/2020/10/15103031058350.shtml",
    "datetime": "2020-10-15 10:30:55",
    "code": "300254"
  },
  {
    "title": "仟源医药：2020年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/10/14220031054137.shtml",
    "datetime": "2020-10-14 22:00:07",
    "code": "300254"
  },
  {
    "title": "仟源医药因药品不合规遭处罚 品牌形象受损难估量",
    "href": "http://stock.jrj.com.cn/2020/10/10185131016428.shtml",
    "datetime": "2020-10-10 18:51:17",
    "code": "300254"
  },
  {
    "title": "仟源医药因药品不合规遭处罚 品牌形象受损难估量",
    "href": "http://stock.jrj.com.cn/2020/09/30073031036033.shtml",
    "datetime": "2020-09-30 07:30:00",
    "code": "300254"
  },
  {
    "title": "仟源医药因药品不合规遭处罚 品牌形象受损难估量",
    "href": "http://stock.jrj.com.cn/2020/09/30073030865150.shtml",
    "datetime": "2020-09-30 07:30:00",
    "code": "300254"
  },
  {
    "title": "仟源医药：公司及各子公司已通过一致性评价的药品将根据市场需求筹备相应货源保证市场供应",
    "href": "http://stock.jrj.com.cn/2020/09/18153230777104.shtml",
    "datetime": "2020-09-18 15:32:53",
    "code": "300254"
  },
  {
    "title": "仟源医药获创业板注册制 小额快速定增项目首单",
    "href": "http://stock.jrj.com.cn/2020/09/18021430772614.shtml",
    "datetime": "2020-09-18 02:14:47",
    "code": "300254"
  },
  {
    "title": "【公告抢先看】晚间重要公告：贵州茅台控股子公司开展固收类有价证券投资业务、仟源医药回应药品不合格……",
    "href": "http://stock.jrj.com.cn/2020/09/15175530756233.shtml",
    "datetime": "2020-09-15 17:55:22",
    "code": "300254"
  },
  {
    "title": "仟源医药回应药品不合格：占比极小 已启动召回暂停生产",
    "href": "http://stock.jrj.com.cn/2020/09/15163830755746.shtml",
    "datetime": "2020-09-15 16:38:35",
    "code": "300254"
  },
  {
    "title": "仟源医药：子公司嘉逸医药“利伐沙班片”获药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/09/14174130748710.shtml",
    "datetime": "2020-09-14 17:41:52",
    "code": "300254"
  },
  {
    "title": "仟源医药(300254.SZ)：“利伐沙班片”获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/09/14161330748053.shtml",
    "datetime": "2020-09-14 16:13:57",
    "code": "300254"
  },
  {
    "title": "[仟源医药] 嘉逸医药高难度仿制药利伐沙班片(嘉伐沙)获得药品批件并视同通过一致性评价",
    "href": "http://stock.jrj.com.cn/2020/09/14000030750868.shtml",
    "datetime": "2020-09-14 00:00:00",
    "code": "300254"
  },
  {
    "title": "仅用3个工作日完成提交注册 仟源医药尝鲜小额定增机制改革红利",
    "href": "http://stock.jrj.com.cn/2020/09/12020330733485.shtml",
    "datetime": "2020-09-12 02:03:42",
    "code": "300254"
  },
  {
    "title": "仟源医药2020年上半年亏损7522.96万由盈转亏 金融负债增加",
    "href": "http://stock.jrj.com.cn/2020/08/27173130605280.shtml",
    "datetime": "2020-08-27 17:31:16",
    "code": "300254"
  },
  {
    "title": "仟源医药上半年亏损7522.96万 主力产品销售滑坡，翻身或靠带量采购",
    "href": "http://stock.jrj.com.cn/2020/08/27135830603921.shtml",
    "datetime": "2020-08-27 13:58:31",
    "code": "300254"
  },
  {
    "title": "【龙虎榜】仟源医药8月21日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/08/21180630558702.shtml",
    "datetime": "2020-08-21 18:06:54",
    "code": "300254"
  },
  {
    "title": "仟源医药4药品全国药品集采拟中标 将对未来经营业绩产生积极影响",
    "href": "http://stock.jrj.com.cn/2020/08/21100930555656.shtml",
    "datetime": "2020-08-21 10:09:27",
    "code": "300254"
  },
  {
    "title": "[仟源医药] 仟源医药及子公司第三批集采4个药品全部中标",
    "href": "http://stock.jrj.com.cn/2020/08/21000030557966.shtml",
    "datetime": "2020-08-21 00:00:00",
    "code": "300254"
  },
  {
    "title": "仟源医药子公司阿哌沙班片获得药品注册批件 视同通过一致性评价",
    "href": "http://stock.jrj.com.cn/2020/08/20091830546524.shtml",
    "datetime": "2020-08-20 09:18:57",
    "code": "300254"
  },
  {
    "title": "仟源医药子公司阿哌沙班片获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/08/19200030540968.shtml",
    "datetime": "2020-08-19 20:00:48",
    "code": "300254"
  },
  {
    "title": "[仟源医药] 仟源医药荣获“心怀大爱,战疫担当”荣誉称号",
    "href": "http://stock.jrj.com.cn/2020/08/19000030536976.shtml",
    "datetime": "2020-08-19 00:00:00",
    "code": "300254"
  },
  {
    "title": "[仟源医药] 重磅!嘉逸医药高难度仿制药阿哌沙班片(逸派平)获得药品批件并通过一致性评价",
    "href": "http://stock.jrj.com.cn/2020/08/19000030539550.shtml",
    "datetime": "2020-08-19 00:00:00",
    "code": "300254"
  },
  {
    "title": "仟源医药股东一致行动协议到期终止 公司无实控人",
    "href": "http://stock.jrj.com.cn/2020/08/14180130500438.shtml",
    "datetime": "2020-08-14 18:01:31",
    "code": "300254"
  },
  {
    "title": "[仟源医药] 必有光芒 必有远方——仟源集团半年度管理及营销工作会议回顾",
    "href": "http://stock.jrj.com.cn/2020/08/12000030530359.shtml",
    "datetime": "2020-08-12 00:00:00",
    "code": "300254"
  },
  {
    "title": "仟源医药拟非公开发行募资不超过1.4亿元 助力产品结构优化",
    "href": "http://stock.jrj.com.cn/2020/08/11092130471271.shtml",
    "datetime": "2020-08-11 09:21:54",
    "code": "300254"
  },
  {
    "title": "[仟源医药] 磷霉素氨丁三醇散「亿欣」正式通过一致性评价",
    "href": "http://stock.jrj.com.cn/2020/08/05000030431241.shtml",
    "datetime": "2020-08-05 00:00:00",
    "code": "300254"
  },
  {
    "title": "仟源医药磷霉素氨丁三醇散通过一致性评价 对公司产生积极影响",
    "href": "http://stock.jrj.com.cn/2020/07/28093430360798.shtml",
    "datetime": "2020-07-28 09:34:38",
    "code": "300254"
  },
  {
    "title": "仟源医药：磷霉素氨丁三醇散通过一致性评价",
    "href": "http://stock.jrj.com.cn/2020/07/27193530356806.shtml",
    "datetime": "2020-07-27 19:35:19",
    "code": "300254"
  },
  {
    "title": "仟源医药：公司有烟酰胺片药品批准文号 但未生产销售该产品",
    "href": "http://stock.jrj.com.cn/2020/07/15163930250862.shtml",
    "datetime": "2020-07-15 16:39:12",
    "code": "300254"
  },
  {
    "title": "仟源医药：2020年半年度业绩报告预告(修正公告)",
    "href": "http://stock.jrj.com.cn/2020/07/15084030245915.shtml",
    "datetime": "2020-07-15 08:40:01",
    "code": "300254"
  },
  {
    "title": "仟源医药2020年上半年预计亏损7200万元-7700万元由盈转亏 销售收入下降幅度较大",
    "href": "http://stock.jrj.com.cn/2020/07/14235730242171.shtml",
    "datetime": "2020-07-14 23:57:01",
    "code": "300254"
  },
  {
    "title": "仟源医药拟以简易程序向特定对象发行股票募资不超1.4亿元",
    "href": "http://stock.jrj.com.cn/2020/06/18214829959609.shtml",
    "datetime": "2020-06-18 21:48:41",
    "code": "300254"
  },
  {
    "title": "仟源医药第一季度亏损4365.01万 较上年同期由盈转亏",
    "href": "http://stock.jrj.com.cn/2020/05/02113429458498.shtml",
    "datetime": "2020-05-02 11:34:53",
    "code": "300254"
  },
  {
    "title": "仟源医药2019年净利529.68万较上年同期减少26.85% 政府扶持资增加较大",
    "href": "http://stock.jrj.com.cn/2020/04/28225029408581.shtml",
    "datetime": "2020-04-28 22:50:44",
    "code": "300254"
  },
  {
    "title": "仟源医药：2020年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/28100029401804.shtml",
    "datetime": "2020-04-28 10:00:03",
    "code": "300254"
  },
  {
    "title": "[仟源医药] 重磅!仟源医药集团子公司嘉逸医药首仿“盐酸西那卡塞片”(嘉格平) 获批上市",
    "href": "http://stock.jrj.com.cn/2020/04/16000029312655.shtml",
    "datetime": "2020-04-16 00:00:00",
    "code": "300254"
  },
  {
    "title": "仟源医药：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/10102029255013.shtml",
    "datetime": "2020-04-10 10:20:00",
    "code": "300254"
  },
  {
    "title": "仟源医药：盐酸氟西汀胶囊通过一致性评价",
    "href": "http://stock.jrj.com.cn/2020/03/13191729022233.shtml",
    "datetime": "2020-03-13 19:17:33",
    "code": "300254"
  },
  {
    "title": "仟源医药：盐酸氟西汀胶囊通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/03/13173529021076.shtml",
    "datetime": "2020-03-13 17:35:00",
    "code": "300254"
  },
  {
    "title": "仟源医药2019年净利润526.35万元下滑27.31% 市场投入增加",
    "href": "http://stock.jrj.com.cn/2020/02/28224828917834.shtml",
    "datetime": "2020-02-28 22:48:38",
    "code": "300254"
  },
  {
    "title": "仟源医药：捐赠价值200万元的药品支援疫情防控",
    "href": "http://stock.jrj.com.cn/2020/02/05162228776662.shtml",
    "datetime": "2020-02-05 16:22:36",
    "code": "300254"
  },
  {
    "title": "仟源医药：捐赠价值200万元的药品支援疫情防控工作",
    "href": "http://stock.jrj.com.cn/2020/02/05161028776614.shtml",
    "datetime": "2020-02-05 16:10:00",
    "code": "300254"
  },
  {
    "title": "仟源医药2019年盈利2000万元–2800万元 同比下降24.91%-46.36%",
    "href": "http://stock.jrj.com.cn/2020/01/23201828729045.shtml",
    "datetime": "2020-01-23 20:18:20",
    "code": "300254"
  },
  {
    "title": "仟源医药：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/23083028725763.shtml",
    "datetime": "2020-01-23 08:30:00",
    "code": "300254"
  },
  {
    "title": "仟源医药：盐酸氨溴索分散片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2020/01/16170928687398.shtml",
    "datetime": "2020-01-16 17:09:00",
    "code": "300254"
  },
  {
    "title": "仟源医药翁占国被曝上市前行贿发审委委员 去年前三季度政府补助超扣非净利",
    "href": "http://stock.jrj.com.cn/2020/01/09150928650097.shtml",
    "datetime": "2020-01-09 15:09:00",
    "code": "300254"
  },
  {
    "title": "仟源医药股东张振标减持173万股 套现约1368万元",
    "href": "http://stock.jrj.com.cn/2020/01/03192928626083.shtml",
    "datetime": "2020-01-03 19:29:19",
    "code": "300254"
  },
  {
    "title": "仟源医药全资子公司西藏仟源获得产业发展扶持资金300万元",
    "href": "http://stock.jrj.com.cn/2020/01/02223028619682.shtml",
    "datetime": "2020-01-02 22:30:08",
    "code": "300254"
  },
  {
    "title": "仟源医药：盐酸坦索罗辛缓释胶囊通过一致性评价",
    "href": "http://stock.jrj.com.cn/2019/12/31181028611258.shtml",
    "datetime": "2019-12-31 18:10:36",
    "code": "300254"
  },
  {
    "title": "仟源医药子公司盐酸坦索罗辛缓释胶囊通过一致性评价",
    "href": "http://stock.jrj.com.cn/2019/12/31175228611558.shtml",
    "datetime": "2019-12-31 17:52:39",
    "code": "300254"
  },
  {
    "title": "仟源医药：子公司盐酸坦索罗辛缓释胶囊通过一致性评价",
    "href": "http://stock.jrj.com.cn/2019/12/31171528611504.shtml",
    "datetime": "2019-12-31 17:15:00",
    "code": "300254"
  },
  {
    "title": "仟源医药为澳医保灵在平安点创申请融资5500万元提供连带保证责任",
    "href": "http://stock.jrj.com.cn/2019/11/29092428466610.shtml",
    "datetime": "2019-11-29 09:24:34",
    "code": "300254"
  },
  {
    "title": "仟源医药收到政府补助金额合计510万元",
    "href": "http://stock.jrj.com.cn/2019/11/23114228441144.shtml",
    "datetime": "2019-11-23 11:42:34",
    "code": "300254"
  },
  {
    "title": "仟源医药与醴泽基金、张宇签署《关于投资江苏嘉逸医药有限公司之合作协议》",
    "href": "http://stock.jrj.com.cn/2019/11/17200628409268.shtml",
    "datetime": "2019-11-17 20:06:19",
    "code": "300254"
  },
  {
    "title": "仟源医药股东张振标拟减持股份 预计减持不超总股本0.83%",
    "href": "http://stock.jrj.com.cn/2019/11/13090128391598.shtml",
    "datetime": "2019-11-13 09:01:24",
    "code": "300254"
  },
  {
    "title": "仟源医药：控股股东及一致行动人拟减持不超0.83%股份",
    "href": "http://stock.jrj.com.cn/2019/11/12175728388961.shtml",
    "datetime": "2019-11-12 17:57:15",
    "code": "300254"
  },
  {
    "title": "仟源医药第三季度盈利147万 同比下滑66.86%",
    "href": "http://stock.jrj.com.cn/2019/10/29085628315768.shtml",
    "datetime": "2019-10-29 08:56:03",
    "code": "300254"
  },
  {
    "title": "仟源医药2019年前三季度净利4260万-4697万 因主营业务相对平稳",
    "href": "http://stock.jrj.com.cn/2019/10/15161128250458.shtml",
    "datetime": "2019-10-15 16:11:58",
    "code": "300254"
  },
  {
    "title": "仟源医药：2019年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/10/14224028245562.shtml",
    "datetime": "2019-10-14 22:40:00",
    "code": "300254"
  },
  {
    "title": "仟源医药子公司蒙脱石散拟中选联盟地区集中采购",
    "href": "http://stock.jrj.com.cn/2019/09/25194228180011.shtml",
    "datetime": "2019-09-25 19:42:37",
    "code": "300254"
  },
  {
    "title": "仟源医药：控股子公司蒙脱石散拟中选联盟地区集中采购",
    "href": "http://stock.jrj.com.cn/2019/09/25182328179386.shtml",
    "datetime": "2019-09-25 18:23:50",
    "code": "300254"
  },
  {
    "title": "仟源医药：子公司蒙脱石散拟中选联盟地区集中采购",
    "href": "http://stock.jrj.com.cn/2019/09/25181128179288.shtml",
    "datetime": "2019-09-25 18:11:00",
    "code": "300254"
  },
  {
    "title": "仟源医药：蒙脱石散通过一致性评价",
    "href": "http://stock.jrj.com.cn/2019/09/06174628101994.shtml",
    "datetime": "2019-09-06 17:46:41",
    "code": "300254"
  },
  {
    "title": "仟源医药：子公司蒙脱石散通过一致性评价",
    "href": "http://stock.jrj.com.cn/2019/09/06170628101744.shtml",
    "datetime": "2019-09-06 17:06:00",
    "code": "300254"
  },
  {
    "title": "仟源医药2019年上半年净利4213万 努力降低生产成本",
    "href": "http://stock.jrj.com.cn/2019/08/29203828057640.shtml",
    "datetime": "2019-08-29 20:38:37",
    "code": "300254"
  },
  {
    "title": "仟源医药13个产品退出新医保目录 将产生较大不利影响",
    "href": "http://stock.jrj.com.cn/2019/08/22221928019085.shtml",
    "datetime": "2019-08-22 22:19:37",
    "code": "300254"
  },
  {
    "title": "公告精选：中国人寿上半年净利同比增128.9%；仟源医药13个产品退出医保目录",
    "href": "http://stock.jrj.com.cn/2019/08/22210128018816.shtml",
    "datetime": "2019-08-22 21:01:00",
    "code": "300254"
  },
  {
    "title": "仟源医药：13个产品退出医保目录 将产生较大不利影响",
    "href": "http://stock.jrj.com.cn/2019/08/22192128018364.shtml",
    "datetime": "2019-08-22 19:21:00",
    "code": "300254"
  },
  {
    "title": "[仟源医药] 仟源医药集团2019年上半年管理年会顺利在德清召开",
    "href": "http://stock.jrj.com.cn/2019/08/08000028227941.shtml",
    "datetime": "2019-08-08 00:00:00",
    "code": "300254"
  },
  {
    "title": "仟源医药：控股股东及其一致人合计减持公司3%股份",
    "href": "http://stock.jrj.com.cn/2019/07/24212027883243.shtml",
    "datetime": "2019-07-24 21:20:48",
    "code": "300254"
  },
  {
    "title": "仟源医药2019年上半年净利4178万-4700万 产业发展扶持基金",
    "href": "http://stock.jrj.com.cn/2019/07/13122627836525.shtml",
    "datetime": "2019-07-13 12:26:54",
    "code": "300254"
  },
  {
    "title": "仟源医药2019年上半年净利4178万-4700万 全资子公司收到扶持基金",
    "href": "http://stock.jrj.com.cn/2019/07/13082027835947.shtml",
    "datetime": "2019-07-13 08:20:10",
    "code": "300254"
  },
  {
    "title": "仟源医药股东俞俊贤拟减持股份 预计减持不超总股本0.17%",
    "href": "http://stock.jrj.com.cn/2019/06/29170127773008.shtml",
    "datetime": "2019-06-29 17:01:59",
    "code": "300254"
  },
  {
    "title": "[仟源医药] “同舟共济·共舆而驰”--2019仟源医药客户研讨暨客户答谢会成功举行",
    "href": "http://stock.jrj.com.cn/2019/05/31000027647724.shtml",
    "datetime": "2019-05-31 00:00:00",
    "code": "300254"
  },
  {
    "title": "仟源医药去年净利724万同比下滑67% 董事长赵群薪酬为60万元",
    "href": "http://stock.jrj.com.cn/2019/04/29232427509790.shtml",
    "datetime": "2019-04-29 23:24:05",
    "code": "300254"
  },
  {
    "title": "仟源医药：控股股东、一致行动人等拟合计减持不超6％股份",
    "href": "http://stock.jrj.com.cn/2019/04/18214427424545.shtml",
    "datetime": "2019-04-18 21:44:19",
    "code": "300254"
  },
  {
    "title": "仟源医药：控股股东及其一致行动人等拟合计减持不超6%股份",
    "href": "http://stock.jrj.com.cn/2019/04/18182427423605.shtml",
    "datetime": "2019-04-18 18:24:00",
    "code": "300254"
  },
  {
    "title": "仟源医药：一季度净利预增160%-190%",
    "href": "http://stock.jrj.com.cn/2019/04/09172127355095.shtml",
    "datetime": "2019-04-09 17:21:50",
    "code": "300254"
  },
  {
    "title": "仟源医药实际控制人翁占国质押200万股 用于补充质押",
    "href": "http://stock.jrj.com.cn/2018/10/18075525218968.shtml",
    "datetime": "2018-10-18 07:55:00",
    "code": "300254"
  },
  {
    "title": "仟源医药：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/12175025196613.shtml",
    "datetime": "2018-10-12 17:50:00",
    "code": "300254"
  },
  {
    "title": "[仟源医药] 传承创新中药炮制技术--四川仟源中药炮制技术传承基地正式启动",
    "href": "http://stock.jrj.com.cn/2018/09/11000026754765.shtml",
    "datetime": "2018-09-11 00:00:00",
    "code": "300254"
  },
  {
    "title": "仟源医药：子公司四川仟源获新版GMP证书",
    "href": "http://stock.jrj.com.cn/2018/08/16173524962518.shtml",
    "datetime": "2018-08-16 17:35:00",
    "code": "300254"
  },
  {
    "title": "仟源医药：医疗健康服务中的基因保存、孕环检检测目前已在京东开设网店",
    "href": "http://stock.jrj.com.cn/2018/08/03161524902609.shtml",
    "datetime": "2018-08-03 16:15:00",
    "code": "300254"
  },
  {
    "title": "仟源医药：医疗健康服务方面合作医院约130余家",
    "href": "http://stock.jrj.com.cn/2018/07/29095524875378.shtml",
    "datetime": "2018-07-29 09:55:00",
    "code": "300254"
  },
  {
    "title": "[仟源医药] “勇做时代的芳华 奋斗的蛟龙”--仟源医药集团2018年管理半年会议在舟山顺利召开",
    "href": "http://stock.jrj.com.cn/2018/07/20000024890667.shtml",
    "datetime": "2018-07-20 00:00:00",
    "code": "300254"
  },
  {
    "title": "[仟源医药] 海力生制药 “开工投产仪式”隆重举行",
    "href": "http://stock.jrj.com.cn/2018/04/28000025289252.shtml",
    "datetime": "2018-04-28 00:00:00",
    "code": "300254"
  },
  {
    "title": "仟源医药控股子公司获得新版GMP证书",
    "href": "http://stock.jrj.com.cn/2018/04/27092624462574.shtml",
    "datetime": "2018-04-27 09:26:00",
    "code": "300254"
  },
  {
    "title": "仟源医药获得新版GMP证书",
    "href": "http://stock.jrj.com.cn/2018/04/20170324423732.shtml",
    "datetime": "2018-04-20 17:03:00",
    "code": "300254"
  },
  {
    "title": "仟源医药：2018年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/04/09212024364374.shtml",
    "datetime": "2018-04-09 21:20:00",
    "code": "300254"
  },
  {
    "title": "[仟源医药] 2018仟源医药集团第二届制药科技大会——探索突破 决胜一致性",
    "href": "http://stock.jrj.com.cn/2018/04/04000025289251.shtml",
    "datetime": "2018-04-04 00:00:00",
    "code": "300254"
  },
  {
    "title": "[仟源医药] 营销事业部2018年保健品销售年会在杭州举行",
    "href": "http://stock.jrj.com.cn/2018/03/09000024428894.shtml",
    "datetime": "2018-03-09 00:00:00",
    "code": "300254"
  },
  {
    "title": "[仟源医药] 集团2018年营销年会在嘉兴举行",
    "href": "http://stock.jrj.com.cn/2018/03/07000024428893.shtml",
    "datetime": "2018-03-07 00:00:00",
    "code": "300254"
  },
  {
    "title": "[仟源医药] 保灵药业2018年经济工作会议在杭州顺利召开",
    "href": "http://stock.jrj.com.cn/2018/02/09000024428895.shtml",
    "datetime": "2018-02-09 00:00:00",
    "code": "300254"
  },
  {
    "title": "仟源医药：2017年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/01/30163024031439.shtml",
    "datetime": "2018-01-30 16:30:00",
    "code": "300254"
  },
  {
    "title": "[仟源医药] 海力生制药迎来厂区乔迁之喜",
    "href": "http://stock.jrj.com.cn/2018/01/28000024428892.shtml",
    "datetime": "2018-01-28 00:00:00",
    "code": "300254"
  },
  {
    "title": "[仟源医药] 恩氏基因2017年年度工作会议在杭州顺利召开",
    "href": "http://stock.jrj.com.cn/2018/01/26000024428888.shtml",
    "datetime": "2018-01-26 00:00:00",
    "code": "300254"
  },
  {
    "title": "[仟源医药] 集团副总裁钟海荣参加中共仟源医药2018年度党工工作会议",
    "href": "http://stock.jrj.com.cn/2018/01/19000024428891.shtml",
    "datetime": "2018-01-19 00:00:00",
    "code": "300254"
  },
  {
    "title": "[仟源医药] 仟源制造2018年度工作会议在大同顺利召开",
    "href": "http://stock.jrj.com.cn/2018/01/18000024428889.shtml",
    "datetime": "2018-01-18 00:00:00",
    "code": "300254"
  },
  {
    "title": "[仟源医药] “练内功·行仟里”集团评优审核会议在上海举行",
    "href": "http://stock.jrj.com.cn/2018/01/16000024428890.shtml",
    "datetime": "2018-01-16 00:00:00",
    "code": "300254"
  },
  {
    "title": "[仟源医药] “尿路感染规范化治疗参学研讨基地学习班”(四川站)圆满落幕",
    "href": "http://stock.jrj.com.cn/2017/12/08000023909342.shtml",
    "datetime": "2017-12-08 00:00:00",
    "code": "300254"
  },
  {
    "title": "[仟源医药] 集团总裁左学民到杭州调研口服固体制剂中试实验室建设项目",
    "href": "http://stock.jrj.com.cn/2017/06/15000024504323.shtml",
    "datetime": "2017-06-15 00:00:00",
    "code": "300254"
  },
  {
    "title": "仟源医药股东减持344万股",
    "href": "http://stock.jrj.com.cn/2016/06/24202121112371.shtml",
    "datetime": "2016-06-24 20:21:00",
    "code": "300254"
  },
  {
    "title": "仟源医药：取得药物临床试验批件 影响较小",
    "href": "http://stock.jrj.com.cn/2016/06/23180221106701.shtml",
    "datetime": "2016-06-23 18:02:40",
    "code": "300254"
  },
  {
    "title": "仟源医药拟定增31亿元 收购普德药业",
    "href": "http://stock.jrj.com.cn/2016/06/21194021096701.shtml",
    "datetime": "2016-06-21 19:40:00",
    "code": "300254"
  },
  {
    "title": "仟源医药：拟出资人民币700万元设立子公司",
    "href": "http://stock.jrj.com.cn/hotstock/2016/05/31075921017420.shtml",
    "datetime": "2016-05-31 07:59:58",
    "code": "300254"
  },
  {
    "title": "仟源医药主打药现玻璃碴子",
    "href": "http://stock.jrj.com.cn/2015/09/18090319831762.shtml",
    "datetime": "2015-09-18 09:03:31",
    "code": "300254"
  },
  {
    "title": "仟源医药遭机构甩卖",
    "href": "http://stock.jrj.com.cn/2014/12/18012118555506.shtml",
    "datetime": "2014-12-18 01:21:42",
    "code": "300254"
  },
  {
    "title": "仟源医药收购恩氏基因80%股权",
    "href": "http://stock.jrj.com.cn/2014/11/12083218338929.shtml",
    "datetime": "2014-11-12 08:32:31",
    "code": "300254"
  },
  {
    "title": "仟源医药：收到国有建设用地使用权补偿款1687.33 万元",
    "href": "http://stock.jrj.com.cn/hotstock/2014/11/12075918338573.shtml",
    "datetime": "2014-11-12 07:59:53",
    "code": "300254"
  },
  {
    "title": "仟源医药：拟向孙公司澳医保灵增资3900万",
    "href": "http://stock.jrj.com.cn/hotstock/2014/10/23075918218665.shtml",
    "datetime": "2014-10-23 07:59:50",
    "code": "300254"
  },
  {
    "title": "仟源医药：拟与磐霖资本共同设立产业基金",
    "href": "http://stock.jrj.com.cn/hotstock/2014/09/25075918075083.shtml",
    "datetime": "2014-09-25 07:59:54",
    "code": "300254"
  },
  {
    "title": "仟源医药拟募资3.87亿 实控人及管理人员认购",
    "href": "http://stock.jrj.com.cn/2014/09/24212418072886.shtml",
    "datetime": "2014-09-24 21:24:02",
    "code": "300254"
  },
  {
    "title": "仟源制药：子公司获得新版GMP证书",
    "href": "http://stock.jrj.com.cn/hotstock/2014/08/22075917862802.shtml",
    "datetime": "2014-08-22 07:59:47",
    "code": "300254"
  },
  {
    "title": "仟源制药子公司5893万出售杭州市江干区房产",
    "href": "http://stock.jrj.com.cn/2014/03/10211516837055.shtml",
    "datetime": "2014-03-10 21:15:09",
    "code": "300254"
  },
  {
    "title": "仟源制药：筹划重大资产重组",
    "href": "http://stock.jrj.com.cn/hotstock/2013/11/01080016068360.shtml",
    "datetime": "2013-11-01 08:00:22",
    "code": "300254"
  },
  {
    "title": "仟源制药筹划重大重组 11月1日起停牌",
    "href": "http://stock.jrj.com.cn/invest/2013/10/31181816065345.shtml",
    "datetime": "2013-10-31 18:18:00",
    "code": "300254"
  },
  {
    "title": "仟源制药获得新版GMP证书",
    "href": "http://stock.jrj.com.cn/2013/07/04213015485204.shtml",
    "datetime": "2013-07-04 21:30:23",
    "code": "300254"
  },
  {
    "title": "仟源制药：控股子公司竞拍获得国有建设用地使用权",
    "href": "http://stock.jrj.com.cn/hotstock/2013/05/08094415284601.shtml",
    "datetime": "2013-05-08 09:44:57",
    "code": "300254"
  },
  {
    "title": "仟源制药收到2109万土地收储补偿款",
    "href": "http://stock.jrj.com.cn/2013/02/20170615070664.shtml",
    "datetime": "2013-02-20 17:06:39",
    "code": "300254"
  },
  {
    "title": "仟源制药取得药监局注册批件",
    "href": "http://stock.jrj.com.cn/2012/09/19142814412726.shtml",
    "datetime": "2012-09-19 14:28:42",
    "code": "300254"
  },
  {
    "title": "仟源制药中签率0.692% 冻结资金522.9亿元",
    "href": "http://stock.jrj.com.cn/ipo/2011/08/09215110689704.shtml",
    "datetime": "2011-08-09 21:51:49",
    "code": "300254"
  },
  {
    "title": "仟源制药：抗生素行业的蓝海探索者",
    "href": "http://stock.jrj.com.cn/hotstock/2011/08/09214810689693.shtml",
    "datetime": "2011-08-09 21:48:48",
    "code": "300254"
  },
  {
    "title": "德邦证券：仟源制药合理价值区间在10.62-12.75元",
    "href": "http://stock.jrj.com.cn/ipo/2011/08/09135310685147.shtml",
    "datetime": "2011-08-09 13:53:05",
    "code": "300254"
  },
  {
    "title": "仟源制药：回归包装求圈钱",
    "href": "http://stock.jrj.com.cn/ipo/2011/06/25162210296531.shtml",
    "datetime": "2011-06-25 16:22:12",
    "code": "300254"
  },
  {
    "title": "创投女杰豪掷1950万入股仟源制药",
    "href": "http://stock.jrj.com.cn/2011/06/23003610272086.shtml",
    "datetime": "2011-06-23 00:36:28",
    "code": "300254"
  }
]